ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105023 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105023; 2) Community: the network communities that were significantly associated with the response to NSC 105023; 3) Molecule: the relationships between components within communities and NSC 105023; 4) MDR: the compounds that were significantly associated with the NSC 105023.

NSC Compound Enrichment Correlation
NSC 624172 Null 0.0278435641331424 0.37880101
NSC 630608 Null 0.0278435641331424 0.42527434
NSC 634035 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.0278435641331424 0.38981317
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.0278435641331424 0.39242544
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.0278435641331424 0.26412237
NSC 639187 Landomycin A 0.0278435641331424 0.47500438
NSC 639981 Null 0.0278435641331424 0.41331754
NSC 645317 Sanguilutine pseudobase 0.0278435641331424 0.41199252
NSC 657270 (+/-) Ethyl trans-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate 0.0278435641331424 0.025059784
NSC 657561 (Z)-4-bromo-4-iodo-3-phenyl-3-buten-2-one 0.0278435641331424 0.39307094
Total:121  Current:81    [First] [Prev] [Next] [Last]